20n Bio

Malvern, United States

20n Bio is a VC-backed start-up dedicated to designing and screening cyclic peptides for therapeutics.

$7.5M raised

May 2026

Seed

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about 20n Bio

How much funding has 20n Bio raised?

20n Bio has raised $7.5M in total funding. The most recent round was Seed. The last funding was announced in May 2026.

Where is 20n Bio headquartered?

20n Bio is headquartered in Malvern, United States.

What does 20n Bio do?

20n Bio is a VC-backed start-up dedicated to designing and screening cyclic peptides for therapeutics.

What stage is 20n Bio at?

20n Bio is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 20, 2026.

MLA

"20n Bio — Funding & Investors." VCBacked, May 20, 2026, https://www.vcbacked.co/company/20n-bio. Accessed July 5, 2026.

APA

VCBacked. (2026). 20n Bio — Funding & Investors. Retrieved July 5, 2026, from https://www.vcbacked.co/company/20n-bio

Wikipedia (cite web)

{{cite web |title=20n Bio — Funding & Investors |url=https://www.vcbacked.co/company/20n-bio |website=VCBacked |access-date=July 5, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 20, 2026.